Silver Book

Silver Book Fact

Around $35 billion cost to society from antibiotic resistant infections

The societal costs of antibiotic resistant infections are around $35 billion each year- this includes the cost of lost wages and premature deaths.

Rboerts R, Hota B, Ahmad I, Scott R, et al. Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship. Clin Infect Dis. 2009; 49(8): 1175-84. http://cid.oxfordjournals.org/content/49/8/1175.full

Reference

Title
Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship
Publication
Clin Infect Dis
Publication Date
2009
Authors
Rboerts R, Hota B, Ahmad I, Scott R, et al.
Volume & Issue
Volume 49, Issue 8
Pages
1175-84
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Publications

Healthcare-Associated Infections Factsheet

 https://www.silverbook.org/wp-content/uploads/2015/06/Screen-Shot-2015-06-30-at-3.02.28-PM.png Thumbnail

Related Facts

  • ~3/4 of all HAIs occur outside of ICU
    Nearly 3/4 of all hospital-acquired HAIs occur outside of the intensive care unit (ICU).  
  • Majority of physicians treated patient with at least 1 drug-resistant infection
    63% of surveyed infectious disease physicians treated a patient with at least one drug-resistant infection in 2011. 56% believed those infections to be on the rise.  
  • Source of 99,000 annual deaths from HAIs
    Of the 99,000 annual deaths from HAIs: 35,967 are from pneumonia 30,665 are from bloodstream infections 13,088 are from urinary tract infections 8,205 are from surgical site infections; and 11,062 are from infections at other…  
  • Around $35 billion cost to society from antibiotic resistant infections
    The societal costs of antibiotic resistant infections are around $35 billion each year- this includes the cost of lost wages and premature deaths.  
  • MRSA infections increase in older patients
    In 2008, 75% of healthcare-associated invasive MRSA infections occurred in patients older than 50, with 46% in patients older than 65%.